4-phenylbutyric acid has been researched along with sodium benzoate in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (57.14) | 24.3611 |
2020's | 3 (42.86) | 2.80 |
Authors | Studies |
---|---|
Erez, A; Lee, B; Nagamani, SC | 1 |
Finnegan, J; Giva, S; Ihidero, P; Knerr, I; Maguire, G; Monavari, A; Power, B | 1 |
Favier, RP; Mesu, SJ; Rothuizen, J; Spee, B; Teske, E; van Dalen, D; van Geijlswijk, IM; van Straten, G | 1 |
Boussery, K; De Spiegeleer, B; Peeters, E; Remon, JP; Van Tongelen, I; Vanhoorne, V; Vervaet, C; Wynendaele, E | 1 |
Birchansky, S; Mangum, R; Soler-Alfonso, C; Stevens, A | 1 |
Ando, Y; Arisaka, O; Imataka, G; Ishii, J; Nitta, A; Takagi, Y; Yoshihara, S | 1 |
Altintas, B; Eldem, I; Langley, R; Lee, A; Nguyen, H; Shinawi, M; Willis, D | 1 |
1 review(s) available for 4-phenylbutyric acid and sodium benzoate
Article | Year |
---|---|
Argininosuccinate lyase deficiency.
Topics: Arginine; Argininosuccinate Lyase; Argininosuccinic Acid; Argininosuccinic Aciduria; Child, Preschool; Citrulline; Cognition Disorders; Diet, Protein-Restricted; Fumarates; Genetic Testing; Glucose; Humans; Hyperammonemia; Hypertension; Infant; Infant, Newborn; Lipids; Liver Diseases; Liver Transplantation; Neonatal Screening; Phenylbutyrates; Sodium Benzoate | 2012 |
1 trial(s) available for 4-phenylbutyric acid and sodium benzoate
Article | Year |
---|---|
Efficacy of orally administered sodium benzoate and sodium phenylbutyrate in dogs with congenital portosystemic shunts.
Topics: Ammonia; Animals; Bile Acids and Salts; Cross-Over Studies; Dogs; Double-Blind Method; Female; Hyperammonemia; Male; Phenylbutyrates; Portal Vein; Random Allocation; Sodium Benzoate; Vascular Malformations | 2019 |
5 other study(ies) available for 4-phenylbutyric acid and sodium benzoate
Article | Year |
---|---|
Hyperammonaemia in Neonates and Young Children: Potential Metabolic Causes, Diagnostic Approaches and Clinical Consequences
Topics: Ammonia; Arginine; Biomarkers; Brain Diseases, Metabolic, Inborn; Carnitine; Critical Illness; Diet, Protein-Restricted; Early Diagnosis; Emergencies; Female; Humans; Hyperammonemia; Infant; Infant, Newborn; Male; Phenylbutyrates; Sodium Benzoate; Treatment Outcome | 2019 |
Pharmaceutical compounding of orphan active ingredients in Belgium: how community and hospital pharmacists can address the needs of patients with rare diseases.
Topics: Arginine; Belgium; Carnitine; Drug Compounding; Excipients; Humans; Pharmacists; Phenylbutyrates; Primaquine; Pyridoxal Phosphate; Rare Diseases; Sodium Benzoate | 2019 |
Survival and Neurologic Recovery After Prompt Diagnosis and Aggressive Management of Severe Idiopathic Hyperammonemic Encephalopathy in a Patient with Acute Myeloid Leukemia.
Topics: Adult; Brain Diseases; Female; Humans; Hyperammonemia; Leukemia, Myeloid, Acute; Neurotoxicity Syndromes; Phenylbutyrates; Prognosis; Sodium Benzoate; Survival Rate; Young Adult | 2020 |
Long-term survival of a patient with acute neonatal-onset metabolic encephalopathy with carbamoyl phosphate synthetase 1 deficiency.
Topics: Arginine; Brain Diseases, Metabolic; Carbamoyl-Phosphate Synthase I Deficiency Disease; Carnitine; Female; Humans; Hyperammonemia; Infant, Newborn; Phenylbutyrates; Renal Dialysis; Sodium Benzoate | 2020 |
Treatment and outcomes of symptomatic hyperammonemia following asparaginase therapy in children with acute lymphoblastic leukemia.
Topics: Ammonia; Antineoplastic Agents; Asparaginase; Child; Glutamine; Humans; Hyperammonemia; Phenylbutyrates; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sodium Benzoate; Treatment Outcome | 2023 |